Organs On Chips: The Silver Bullet Pharma Is Priming To Fire

In this two-part series, In Vivo will explore why organ on chip technology exists, the factors driving and limiting their application in drug development, and how companies can benefit from using them.    

Gun
• Source: Shutterstock

The cost of developing and taking a new drug to market can range from a hair under a billion to almost $3bn, with a study from the London School of Economics giving an average of $1.3bn.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Innovation

More from In Vivo